anygenkorea

[anygenkorea]

ANYGEN CO., LTD. Is one of the leading in peptide bio-materials and new drugs in Korea

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

A few company have monopoly on peptide drug materials market all over the world. ANYGEN CO., LTD. is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care. In addition, ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales. To thrive as a successful bio-company with active R&D investment and globalization strategies based on a stable cash-flow of peptide APIs manufacturing, every member of ANYGEN CO., LTD. will strive for the best. 

Thank you for your continued support and we hope that you will continue to see our development in the global market.

Generic Peptides

Leuprorelin Acetate, DMF

Cat -KTA-35

Introduction

Sequence- Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt acetate salt

MW- 1209.42

Reference

·         D. H. Coy and A. V. Schally, Ann. Clin. Res., 10, 139 (1978)

·         S. Dutta, Drugs Future, 13, 43 (1988)

·         P. Chrisp and E. M. Sorkin, Drugs & Aging, 1, 487 (1991)

·         T. Mizutani et al., Int. J. Fertil. Menopaus. Stud., 40, 106 (1995)

·         Imai et al., Int. J. Oncol., 20, 987 (2002)

·         J. D. Meyer et al., J. Pept. Res., 60, 159 (2002)

·         E. Castell?n et al., Cancer Invest., 24, 261 (2006)

·         Merck Index, 14th ed., No. 5457, (2006)

·         D. Levine et al., J. Reprod. Med., 52, 581 (2007)

Goserelin Acetate

Cat -KTA-32

Introduction

Goserellin Acetate is a potent LHRH agonist. After a transient increase, continuous administration results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis.

Sequence

Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2 Acetate salt

MW

1269.43

Reference

·         Wells et al., Clin. Cancer Res., 8, 1251 (2002)

·         H. Lepor, Rev. Urol., 7 (Suppl. 5), S3 (2005)

·         Rody et al., Expert Rev. Anticancer Ther., 5, 591 (2005)

·         Merck Index, 14th ed., No. 4526, (2006)

·         M. Roach 3rd and A. Izaguirre, Expert Opin. Pharmacother., 8, 257 (2007)

·         R. M. Herrmann et al., Rad. Oncol., 2, 31 (2007)

Fields of application

·         Advanced hormone-dependent prostate cancer

·         Advanced hormone-dependent Breast cancer

·         Endometriosis

·         Uterine myoma

·         Use in reproductive medicine

Synonyms

·         (D-Ser(tBu)6,Azagly10)-LHRH

Are you looking for a GMP Peptides manufacturer and Leuprorelin Acetate Manufacturer in Korea? ANYGEN CO., LTD. is specialized in the development of peptide bio-materials and new drugs products in Korea.

[anygenkorea]

ANYGEN CO., LTD provides high-quality peptides using the rich experience of peptide synthesis and optimized synthesis technology.

ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales. To thrive as a successful bio-company with active R&D investment and globalization strategies based on a stable cash-flow of peptide APIs manufacturing, every member of ANYGEN CO., LTD. will strive for the best.

Catalog Peptides

Catalog Products for you R & D needs:

Catalog Peptides are research peptides that are widely known for their physiological activities such as Hormone, Neuropeptide, Antibiotic peptide, and Neurotoxin. Anisen has about 1,000 cataloged peptides focused on CPCR Ligards and Peptide Neurotoxins and supplies small quantities at low prices.

Products are listed by categories and if you need to search, please use Smart Search in the top right corner. If you need more than the package shown, please put the product into your shopping cart and record the required amount in the other field and we will contact you. We promise to up-date the catalog peptide continuously to meet customers' needs. The order of the peptides is> 95% by HPLC unless otherwise indicated. Unless otherwise indicated, the counter ion of all peptides is TFA (Trifluoroacetic)

Custom Peptides

It’s provides fast delivery of high-quality peptides of various kinds to the customer using the rich experience of peptide synthesis and optimized synthesis technology.

Other Service

MALDI-TOF Mass Spectrometer

ㆍ Model name AXIMA-Assurance

ㆍ Manufacturer Shimadzu

ㆍ Price: 50,000 won / sample

ㆍ Contact Information 062-714-1166

ㆍ Feature It is a high-resolution mass spectrometer that measures ions at the ratio of mass to charge using electric field and magnetic field. It can measure the molecular weight of biopolymers such as peptides, proteins, lipids, and nucleic acids by using a tandem technique using various ion sources and High Energy Collision.

High performance liquid chromatography

(High Performance Liquid Chromatography)

ㆍ Model name Shimadzu 10Avp

ㆍ Manufacturer Shimadzu

ㆍ Price: 100,000 won / sample

ㆍ Contact Information 062-714-1166

ㆍ Characteristics It means that the mixed sample components are separated into single components by adsorption, distribution, ion exchange or molecular size disposal by flowing between the mobile phase and the stationary phase. Separation, qualification, quantification, etc., and for separation, purification and purification purposes.

If you want Custom Peptide Synthesis in Korea and Catalog Peptides in Korea? ANYGEN CO., LTD. utilizes a wealth of experience in peptide synthesis and optimized synthesis techniques to quickly provide a wide range of high-quality peptides that the customer desires.

[anygenkorea]

ANYGEN CO., LTD  has developed peptide biomaterial process and quality management technology in korea

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

Manufacture of peptide API according to GMP regulation

Angien's GMP plant is Korea's first facility specialized in the production of peptide drug raw materials, and has all the equipment and infrastructure necessary for the synthesis, purification, drying and quality control of peptide drug raw materials. It has been designed and manufactured to meet the standards of excellent pharmaceutical manufacturing facilities. It has been approved by the Food and Drug Administration (MFDS) for the first time in Korea to be approved for the manufacture and quality control of peptide raw materials and approval for GMP.

GMP workshop facilities and possible work

Large volume solid and liquid reaction

QA / QC and documentation support

Large volume HPLC purification

All specialized production technologies for peptides

Freeze-dried Compliant with GMP regulations

Clean room of Class 10,000 and Class 100,000

Wide range from R & D to commercialization

Synthetic technology

Based on the accumulated know-how and know-how for more than 15 years, Ani-zen has established various synthesis methods for peptide characteristics, and the synthesis method is applied in accordance with amino acid composition, length, scale and customer's request.

Solid Phase Peptide Synthesis

It is a synthetic technique applied to the manufacture of most peptides up to several kilograms, especially for the synthesis of long chain peptides or complex sequence peptides. Based on Fmoc, we apply the solid phase production method

•             Solution Phase Peptide Synthesis

Applies to the production of relatively short peptides and provides economical manufacturing processes from g to several kg per lot

•             Convergent Peptide Synthesis

This technology is a technique for producing peptides by binding short peptides prepared by solid phase synthesis in a liquid phase, and is suitable for the production of long chain peptides

Are you looking for a Peptide Biomaterials Drugs Products in Korea and Peptide APIs in Korea? ANYGEN CO., LTD.'s GMP plant is Korea's first facility specialized in the production of peptide drug raw materials, and has the facilities and infrastructure necessary for the synthesis, purification, drying and quality control of peptide drug raw materials.

[anygenkorea]

ANYGEN CO.,LTD bio-venture of Exenatide Acetate Sequences and fields of applications

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

A few company have monopoly on peptide drug materials market all over the world. Anygen co., ltd. Is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care. Provide a wide range of high quality peptides that the customer desires. A few company have monopoly on peptide drug materials market all over the world. ANYGEN CO., LTD. is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care. In addition, ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales.

Synonyms:

(D-Ser(tBu)6,Azagly10)-LHRH

Exenatide Acetate

Exendin-4 (exenatide), a 39-amino acid peptide originally isolated from the salivary glands of the Gila monster  (Heloderma suspectum), differs from exendin-3 only in two positions close to the N-terminus. Application of exenatide causes an increase in acinar cAMP without stimulating amylase release. As an incretin mimetic, exenatide acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. As GLP-1, though with prolonged activity, exenatide augments the postprandial production of insulin and suppresses secretion of glucagon. For this reason, exenatide has found use as a medication of diabetes II. This product is offered under Bolar Exemption. Generic Peptides Manufacturer in Korea

Sequences:

H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 acetate salt

Fields of applications:

Type 2 diabetes

Are you looking for a Research Peptide drugs Manufacturer in Korea and Peptide Biomaterials Drugs Products in Korea? Ganirelix Acetate  Based on our accumulated technology and know-how for over ten years ANYGEN has established various synthesis methods for peptide characteristics, and the composition and length of amino acid, scale, and the synthesis method that is characterized by customer's request are selected.

[anygenkorea]

ANYGEN CO., LTD is specialized in the development of peptide bio-materials and new drugs products in Korea

Anygen co., ltd. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales.

A few company have monopoly on peptide drug materials market all over the world. Anygen co., ltd. Is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care. Provide a wide range of high quality peptides that the customer desires. A few company have monopoly on peptide drug materials market all over the world. ANYGEN CO., LTD. is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care.In addition, ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales. To thrive as a successful bio-company with active R&D investment and globalization strategies based on a stable cash-flow of peptide APIs manufacturing, every member of ANYGEN CO., LTD. will strive for the best. 

Introduction

Goserellin Acetate is a potent LHRH agonist. After a transient increase, continuous administration results in down regulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis.

Sequence

Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2 Acetate salt

MW

1269.43

Reference

·         Wells et al., Clin. Cancer Res., 8, 1251 (2002)

·         H. Lepor, Rev. Urol., 7 (Suppl. 5), S3 (2005)

·         Rody et al., Expert Rev. Anticancer Ther., 5, 591 (2005)

·         Merck Index, 14th ed., No. 4526, (2006)

·         M. Roach 3rd and A. Izaguirre, Expert Opin. Pharmacother., 8, 257 (2007)

·         R. M. Herrmann et al., Rad. Oncol., 2, 31 (2007)

Fields of application

·         Advanced hormone-dependent prostate cancer

·         Advanced hormone-dependent Breast cancer

·         Endometriosis

·         Uterine myoma

·         Use in reproductive medicine

Synonyms

·         (D-Ser(tBu)6,Azagly10)-LHRH

Are you looking for a

GMP Peptides manufacturer

and

Leuprorelin Acetate Manufacturer in Korea

?

[anygenkorea]

Anygen Co.,LTD Catalog Peptides and Manufacture of Peptide APIs according to GMP regulations

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

A few company have monopoly on peptide drug materials market all over the world. ANYGEN CO., LTD. is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care.

In addition, ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales.

Peptides:

Catalog Peptides

Catalog Peptides in Korea include Hormones, Neuropeptides, Antibiotic peptides, and Neurotoxins, which are research-use peptides widely known for their physiologically active properties. ANYGEN holds about 1000 types of catalog peptides focused on GPCR ligands and peptide Neurotoxins and provides small quantities of products at inexpensive prices. Research Peptide drugs Manufacturer in Korea

The products have been organized and listed by category and to search, please use the smart search on the upper left-hand corner. If a larger amount than the marked package is needed, please place the product in the Shopping Cart, write the amount necessary in the "Other" space, and send us your order. We will contact you back immediately. To satisfy the client's needs, we promise to continue updating Catalog Peptides.

Manufacture of peptide APIs according to GMP regulations:

ANYGEN CO., LTD.'s GMP plant is Korea's first facility specialized in the production of peptide drug raw materials, and has the facilities and infrastructure necessary for the synthesis, purification, drying and quality control of peptide drug raw materials. It has been designed and manufactured to meet the Peptide Biomaterials Drugs Products in Korea standards of excellent pharmaceutical manufacturing facilities and has been approved by the Ministry of Food And Drug Safety (MFDS) for the first time in Korea to approve the manufacture and quality control of peptide drugs and approval for GMP. Peptide APIs korea

[anygenkorea]

ANYGEN CO., LTD. has supplied custom peptide products in local pharmaceutical companies in Korea

Anygen co., ltd. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales.

A few company have monopoly on peptide drug materials market all over the world. Anygen co., ltd. Is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care. Provide a wide range of high quality peptides that the customer desires.

Peptide bio-material manufacturing:

GMP

·         Leuprorelin

·         Desmopressin

·         Exenatide

·         Ziconotide

·         CMO

Non-GMP

·         Peptide for Research, study

·         Peptide for cosmetic

Amino acid-based peptide bio-new drug development:

·         AGM-130 (Breast cancer treatment)

·         AGM-212 (Type 2 diabetes treatment)

·         AGM-251 (Neuropathic pain treatment)

·         AGM-290 (MRSA infection treatment)

Generic Peptides

Leuprorelin Acetate, DMF

Cat -KTA-35

Introduction

Sequence- Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt acetate salt

MW- 1209.42

Reference

·         D. H. Coy and A. V. Schally, Ann. Clin. Res., 10, 139 (1978)

·         S. Dutta, Drugs Future, 13, 43 (1988)

·         P. Chrisp and E. M. Sorkin, Drugs & Aging, 1, 487 (1991)

·         T. Mizutani et al., Int. J. Fertil. Menopaus. Stud., 40, 106 (1995)

·         Imai et al., Int. J. Oncol., 20, 987 (2002)

·         J. D. Meyer et al., J. Pept. Res., 60, 159 (2002)

·         E. Castell?n et al., Cancer Invest., 24, 261 (2006)

·         Merck Index, 14th ed., No. 5457, (2006)

·         D. Levine et al., J. Reprod. Med., 52, 581 (2007)

Goserelin Acetate

Cat -KTA-32

Introduction

Goserellin Acetate is a potent LHRH agonist. After a transient increase, continuous administration results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. bio-venture company in korea

Sequence

Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2 Acetate salt

MW

1269.43

Reference

·         Wells et al., Clin. Cancer Res., 8, 1251 (2002)

·         H. Lepor, Rev. Urol., 7 (Suppl. 5), S3 (2005)

·         Rody et al., Expert Rev. Anticancer Ther., 5, 591 (2005)

·         Merck Index, 14th ed., No. 4526, (2006)

·         M. Roach 3rd and A. Izaguirre, Expert Opin. Pharmacother., 8, 257 (2007)

·         R. M. Herrmann et al., Rad. Oncol., 2, 31 (2007) GMP Peptides in Korea

[anygenkorea]

Specialized in the development of peptide bio-materials and new drugs in korea- ANYGEN CO., LTD

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

In addition, ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales.

We will secure stable cash flow through the production and production of peptide biomaterials, and will actively invest in R & D for amino acid and peptide-based drug candidates, and establish a globalization strategy to build a global bio-venture company with international competitiveness and sustainable growth. We want to present a successful and ideal model.

Manufacture of peptide APIs according to GMP regulations:

ANYGEN CO., LTD.'s GMP plant is Korea's first facility specialized in the production of peptide drug raw materials, and has the facilities and infrastructure necessary for the synthesis, purification, drying and quality control of peptide drug raw materials. It has been designed and manufactured to meet the standards of excellent pharmaceutical manufacturing facilities and has been approved by the Ministry of Food and Drug Safety (MFDS) for the first time in Korea to approve the manufacture and quality control of peptide drugs and  Peptide APIs korea

R & D:

We intend to grow into a global biopharmaceutical company through continuous research and development, technology transfer, and commercialization of new drug candidates that have better efficacy and safety than existing drugs and can treat new diseases.

Zen Ltd. Annie with R & D technology to lead the market, and has the Pipeline for new peptide drug development and commercialization.

Are you looking for a Research Peptide drugs Manufacturer in Korea? Based on our accumulated technology and know-how for over ten years, ANYGEN has established various synthesis methods for peptide characteristics, and the composition and length of amino acid, scale, and the synthesis method that is characterized by customer's request are selected.

[anygenkorea]

ANYGEN CO., LTD is on the manufacturing peptide bio-materials and new drugs in Korea

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

In addition, ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales.

Manufacture of peptide APIs according to GMP regulations:

ANYGEN CO., LTD.'s GMP plant is Korea's first facility specialized in the production of peptide drug raw materials, and has the facilities and infrastructure necessary for the synthesis, purification, drying and quality control of peptide drug raw materials. It has been designed and manufactured to meet the standards of excellent pharmaceutical manufacturing facilities and has been approved by the Ministry of Food And Drug Safety (MFDS) for the first time in Korea to approve the manufacture and quality control of peptide drugs and approval for GMP. Peptide APIs korea

Our GMP manufacturing capabilities include:

•             Bulk scale solid & solution phase synthesis

•             Proportionately scaled HPLC Purification.

•             Lyophilization

•             Cleanrooms from Class 100,000 to class 10,000QA/QC and Regulatory support

•             Expertise in all production and purification techniques

•             Dedication to quality and GMP compliance

Looking for a Ganirelix Acetate and Leuprolide Acetate Manufacturer in Korea? ANYGEN CO., LTD. is specialized in the development of peptide bio-materials and new drugs. A few company have monopoly on peptide drug materials market all over the world. Desmopressin Acetate

Sequences:

H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 acetate salt

Thank you for your continued support and we hope that you will continue to see our development in the global market.

[anygenkorea]

ANYGEN CO., LTD. Is one of the leading in peptide bio-materials and new drugs in Korea

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

A few company have monopoly on peptide drug materials market all over the world. ANYGEN CO., LTD. is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care. In addition, ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales. To thrive as a successful bio-company with active R&D investment and globalization strategies based on a stable cash-flow of peptide APIs manufacturing, every member of ANYGEN CO., LTD. will strive for the best. 

Thank you for your continued support and we hope that you will continue to see our development in the global market.

Generic Peptides

Leuprorelin Acetate, DMF

Cat -KTA-35

Introduction

Sequence- Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt acetate salt

MW- 1209.42

Reference

·         D. H. Coy and A. V. Schally, Ann. Clin. Res., 10, 139 (1978)

·         S. Dutta, Drugs Future, 13, 43 (1988)

·         P. Chrisp and E. M. Sorkin, Drugs & Aging, 1, 487 (1991)

·         T. Mizutani et al., Int. J. Fertil. Menopaus. Stud., 40, 106 (1995)

·         Imai et al., Int. J. Oncol., 20, 987 (2002)

·         J. D. Meyer et al., J. Pept. Res., 60, 159 (2002)

·         E. Castell?n et al., Cancer Invest., 24, 261 (2006)

·         Merck Index, 14th ed., No. 5457, (2006)

·         D. Levine et al., J. Reprod. Med., 52, 581 (2007)

Goserelin Acetate

Cat -KTA-32

Introduction

Goserellin Acetate is a potent LHRH agonist. After a transient increase, continuous administration results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis.

Sequence

Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2 Acetate salt

MW

1269.43

Reference

·         Wells et al., Clin. Cancer Res., 8, 1251 (2002)

·         H. Lepor, Rev. Urol., 7 (Suppl. 5), S3 (2005)

·         Rody et al., Expert Rev. Anticancer Ther., 5, 591 (2005)

·         Merck Index, 14th ed., No. 4526, (2006)

·         M. Roach 3rd and A. Izaguirre, Expert Opin. Pharmacother., 8, 257 (2007)

·         R. M. Herrmann et al., Rad. Oncol., 2, 31 (2007)

Fields of application

·         Advanced hormone-dependent prostate cancer

·         Advanced hormone-dependent Breast cancer

·         Endometriosis

·         Uterine myoma

·         Use in reproductive medicine

Synonyms

·         (D-Ser(tBu)6,Azagly10)-LHRH

Are you looking for a GMP Peptides manufacturer and Leuprorelin Acetate Manufacturer in Korea? ANYGEN CO., LTD. is specialized in the development of peptide bio-materials and new drugs products in Korea.

[anygenkorea]

ANYGEN CO., LTD. utilizes a wealth of experience in peptide synthesis and optimized synthesis techniques.

Anygen co., ltd. Has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales.

A few company have monopoly on peptide drug materials market all over the world. Anygen co., ltd. Is the first gmp certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care. provide a wide range of high quality peptides that the customer desires.

Peptide bio-material manufacturing:

GMP

·         Leuprorelin

·         Desmopressin

·         Exenatide

·         Ziconotide

·         CMO

Non-GMP

·         Peptide for Research, study

·         Peptide for cosmetic

Amino acid-based peptide bio-new drug development:

·         AGM-130 (Breast cancer treatment)

·         AGM-212 (Type 2 diabetes treatment)

·         AGM-251 (Neuropathic pain treatment)

·         AGM-290 (MRSA infection treatment)

Peptides:

Catalog Peptides

Catalog Peptides in Korea include Hormones, Neuropeptides, Antibiotic peptides, and Neurotoxins, which are research-use peptides widely known for their physiologically active properties. ANYGEN holds about 1000 types of catalog peptides focused on GPCR ligands and peptide Neurotoxins and provides small quantities of products at inexpensive prices.

The products have been organized and listed by category and to search, please use the smart search on the upper left-hand corner. If a larger amount than the marked package is needed, please place the product in the Shopping Cart, write the amount necessary in the "Other" space, and send us your order. We will contact you back immediately. To satisfy the client's needs, we promise to continue updating Catalog Peptides.

 If you want Custom Peptide Synthesis in Korea? ANYGEN CO., LTD. utilizes a wealth of experience in peptide synthesis and optimized synthesis techniques to quickly provide a wide range of high quality peptides that the customer desires

[anygenkorea]

Overview of a high quality generic peptides produced at GMP facilities in ANYGEN CO., LTD

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

Brief History:

2017

·         Determination of suitability for pharmaceutical manufacturing and quality control standard.

·         Selection of 2017 Korean Small Business Innovation Research Program

·         (Government Task)

·         Acquisition of IP CERT

·         Designated as a High Technology Company

·         Designated as a Global IP Star Company

·         Signed contract for process development, production and stability research

·         (GPC-3, HSP-70 / CYTLIMIC INC.)

·         Purchase of land and buildings for the expansion of Osong No. 2 plant

2016

·         Listed on KOSDAQ market

·         Acquired export license for Leuprorelin / DCGI(India)

·         Designated as a K-Brain Power 2016~2018

2015

·         Strategic alliance Ziconotide With TherDose Phama Pvt (India)

·         Manufacturing Partnership with TONYMOLY (Cosmetic)

·         Approval of clinical trial on AGM-130, Phase1b.

Generic Peptides Ongoing Projects

·         Leuprorelin Acetate, DMF

·         Atosiban Acetate

·         Goserelin Acetate

·         Ganirelix Acetate

·         Exenatide Acetate

·         Cetrorelix Acetate

·         Goserelin Acetate

Goserellin Acetate is a potent LHRH agonist. After a transient increase, continuous administration results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis.

Sequences:

Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2 Acetate salt

Fields of application:

·         Advanced hormone-dependent prostate cancer

·         Advanced hormone-dependent Breast cancer

·         Endometriosis

·         Uterine myoma

·         Use in reproductive medicine

Synonyms:

(D-Ser(tBu)6,Azagly10)-LHRH

Exenatide Acetate

Exendin-4 (exenatide), a 39-amino acid peptide originally isolated from the salivary glands of the Gila monster  (Heloderma suspectum), differs from exendin-3 only in two positions close to the N-terminus. Application of exenatide causes an increase in acinar cAMP without stimulating amylase release. As an incretin mimetic, exenatide acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. As GLP-1, though with prolonged activity, exenatide augments the postprandial production of insulin and suppresses secretion of glucagon. For this reason, exenatide has found use as a medication of diabetes II. This product is offered under Bolar Exemption.

Sequences:

H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 acetate salt

MW:

4186.63

Fields of applications:

Type 2 diabetes

Are you looking for a Research Peptide drugs Manufacturer in Korea and Peptide Biomaterials Drugs Products in Korea? Based on our accumulated technology and know-how for over ten years ANYGEN has established various synthesis methods for peptide characteristics, and the composition and length of amino acid, scale, and the synthesis method that is characterized by customer's request are selected

[anygenkorea]

ANYGEN CO., LTD. is specialized in the development of peptide bio-materials and new drugs.

ANYGEN CO., LTD. is the first bio-venture company in Gwangju and Jeonnam province. It has developed peptide biomaterial process and quality management technology that was developed independently since its establishment in 2000. Based on this, we have localized peptide biomaterials, which had previously relied on imports, and are making efforts to advance into the global market based on superior quality and price competitiveness. In 2016, it was listed on the KOSDAQ based on its proprietary peptide biomaterials and new drug development technology.

A few company have monopoly on peptide drug materials market all over the world. ANYGEN CO., LTD. is the first GMP certified company in domestic, we commercialize peptide drug materials at a reasonable price. We expect to contribute to the advancement of national medical industry and national health care.

In addition, ANYGEN CO., LTD. has supplied custom peptide products in local and international pharmaceutical companies apart from competitors, we contribute to the revitalization of developing a new medicine. Ultimately it is lead to improvements and increase in sales.

To thrive as a successful bio-company with active R&D investment and globalization strategies based on a stable cash-flow of peptide APIs manufacturing, every member of ANYGEN CO., LTD. will strive for the best.

Thank you for your continued support and we hope that you will continue to see our development in the global market.

Manufacture of peptide APIs according to GMP regulations.

ANYGEN CO., LTD.'s GMP plant is Korea's first facility specialized in the production of peptide drug raw materials, and has the facilities and infrastructure necessary for the synthesis, purification, drying and quality control of peptide drug raw materials. It has been designed and manufactured to meet the standards of excellent pharmaceutical manufacturing facilities and has been approved by the Ministry of Food And Drug Safety (MFDS) for the first time in Korea to approve the manufacture and quality control of peptide drugs and approval for GMP.

Our GMP manufacturing capabilities include

·         Bulk scale solid & solution phase synthesis

·         Proportionately scaled HPLC Purification.

·         Lyophilization

·         Cleanrooms from Class 100,000 to class 10,000QA/QC and Regulatory support

·         Expertise in all production and purification techniques

·         Dedication to quality and GMP compliance

Looking for a Ganirelix Acetate and Leuprolide Acetate Manufacturer in Korea? ANYGEN CO., LTD. is specialized in the development of peptide bio-materials and new drugs. A few company have monopoly on peptide drug materials market all over the world.